<p>拥有大量资金的鲸鱼们对 <strong>强生</strong> 采取了明显的看涨态度。</p>
<p>查看强生（纽约证券交易所代码：JNJ）的期权历史，我们发现了 11 笔交易。</p>
<p>如果考虑每笔交易的具体情况，可以准确地说，72% 的投资者以看涨的预期开仓，0% 以看跌的预期开仓。</p>
<p>在所有发现的交易中，有 4 笔是看跌期权，总金额为 411,540 美元，7 笔是看涨期权，总金额为 424,038 美元。</p>
<h3>价格目标是什么？</h3>
<p>分析这些合约的成交量和未平仓合约，似乎大玩家在过去一个季度内关注强生的价格区间为 135.0 美元到 215.0 美元。</p>
<h3>成交量与未平仓合约的发展</h3>
<p>查看成交量和未平仓合约是交易期权时的一个强有力的举措。这些数据可以帮助你跟踪强生在特定行权价的期权流动性和兴趣。下面，我们可以观察到过去 30 天内，强生所有鲸鱼交易的看涨和看跌期权的成交量和未平仓合约的演变，行权价范围为 135.0 美元到 215.0 美元。</p>
<h3>强生 30 天期权成交量与兴趣快照</h3>
<p><img src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2025/1766599293_0.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="期权看涨图表" original-src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2025/1766599293_0.png"/></p>
<h3>发现的重要期权交易：</h3>
<table>
<thead>
<tr>
<th><strong>代码</strong></th>
<th><strong>看跌/看涨</strong></th>
<th><strong>交易类型</strong></th>
<th><strong>情绪</strong></th>
<th><strong>到期日</strong></th>
<th><strong>卖出价</strong></th>
<th><strong>买入价</strong></th>
<th><strong>价格</strong></th>
<th><strong>行权价</strong></th>
<th><strong>总交易价格</strong></th>
<th><strong>未平仓合约</strong></th>
<th align="right"><strong>成交量</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>JNJ</td>
<td>看跌</td>
<td>扫描</td>
<td>看涨</td>
<td>01/16/26</td>
<td>$5.7</td>
<td>$5.5</td>
<td>$5.55</td>
<td>$210.00</td>
<td>$222.0K</td>
<td>4.1K</td>
<td align="right">569</td>
</tr>
<tr>
<td>JNJ</td>
<td>看涨</td>
<td>交易</td>
<td>看涨</td>
<td>03/20/26</td>
<td>$29.85</td>
<td>$28.5</td>
<td>$29.44</td>
<td>$180.00</td>
<td>$147.2K</td>
<td>2.3K</td>
<td align="right">50</td>
</tr>
<tr>
<td>JNJ</td>
<td>看跌</td>
<td>扫描</td>
<td>看涨</td>
<td>01/15/27</td>
<td>$18.5</td>
<td>$17.3</td>
<td>$17.3</td>
<td>$210.00</td>
<td>$103.8K</td>
<td>119</td>
<td align="right">60</td>
</tr>
<tr>
<td>JNJ</td>
<td>看涨</td>
<td>交易</td>
<td>中性</td>
<td>01/15/27</td>
<td>$75.65</td>
<td>$72.7</td>
<td>$74.18</td>
<td>$135.00</td>
<td>$74.1K</td>
<td>363</td>
<td align="right">0</td>
</tr>
<tr>
<td>JNJ</td>
<td>看涨</td>
<td>扫描</td>
<td>看涨</td>
<td>01/02/26</td>
<td>$1.13</td>
<td>$1.04</td>
<td>$1.05</td>
<td>$210.00</td>
<td>$60.5K</td>
<td>469</td>
<td align="right">589</td>
</tr>
</tbody>
</table>
<h3>关于强生</h3>
<p>强生是全球最大的、最具多样性的医疗保健公司。它有两个部门：创新药物和医疗技术。自 2023 年剥离消费业务 Kenvue 以来，这两个部门现在代表了公司所有的销售。在 2023-24 年的重组后，药物部门专注于三个主要治疗领域：免疫学、肿瘤学和神经学。从地域上看，超过一半的总收入来自美国。</p>
<p>在分析了与强生相关的期权活动后，我们转向更仔细地观察公司的自身表现。</p>
<h3>强生的当前状况</h3>
<ul>
<li>当前交易量为 1,499,052，JNJ 的价格下跌了-0.07%，现为 205.64 美元。</li>
<li>RSI 读数表明该股票目前在超买和超卖之间处于中性状态。</li>
<li>预计收益发布将在 28 天内进行。</li>
</ul>
<h3>专家对强生的看法</h3>
<p>在过去 30 天内，共有 5 位专业分析师对该股票发表了看法，设定的平均价格目标为 223.8 美元。</p>
<p><strong>发现异常期权活动：聪明资金在行动</strong></p>
<p>Benzinga Edge 的异常期权板块在潜在市场动向发生之前发现可能的市场推动者。查看大资金在你喜欢的股票上采取了什么头寸。点击这里访问。
* RBC Capital 的一位分析师坚持对强生的跑赢大盘评级，维持目标价为 230 美元。
* B of A Securities 的一位分析师决定维持对强生的中性评级，目前的目标价为 220 美元。
* 摩根士丹利的一位分析师坚持对强生的等权评级，维持目标价为 197 美元。
* 高盛的一位分析师决定维持对强生的买入评级，目前的目标价为 240 美元。
* 花旗的一位分析师在评估中保持对强生的买入评级，目标价为 232 美元。</p>
<p>交易期权涉及更大的风险，但也提供了更高的利润潜力。精明的交易者通过持续教育、战略交易调整、利用各种指标以及关注市场动态来降低这些风险。通过 Benzinga Pro 跟踪强生的最新期权交易，获取实时警报。</p>

强生

<p>鲸鱼们对强生持乐观态度，72% 的期权交易显示出积极情绪。分析师设定的平均目标价为 223.8 美元，评级范围从中性到买入。显著的期权交易包括在 135 美元到 215 美元的行权价范围内的看涨和看跌期权。强生的股票目前处于中性状态，交易价格为 205.64 美元，预计在 28 天内公布财报。来自 RBC、美国银行、摩根士丹利、高盛和花旗的分析师提供了不同的评级和目标价</p>

<p>Whales with a lot of money to spend have taken a noticeably bullish stance on <strong>Johnson &amp; Johnson</strong>.</p>
<div class="lb-trans"><p>拥有大量资金的鲸鱼们对 <strong>强生</strong> 采取了明显的看涨态度。</p>
</div><p>Looking at options history for Johnson &amp; Johnson (NYSE: JNJ) we detected 11 trades.</p>
<div class="lb-trans"><p>查看强生（纽约证券交易所代码：JNJ）的期权历史，我们发现了 11 笔交易。</p>
</div><p>If we consider the specifics of each trade, it is accurate to state that 72% of the investors opened trades with bullish expectations and 0% with bearish.</p>
<div class="lb-trans"><p>如果考虑每笔交易的具体情况，可以准确地说，72% 的投资者以看涨的预期开仓，0% 以看跌的预期开仓。</p>
</div><p>From the overall spotted trades, 4 are puts, for a total amount of $411,540 and 7, calls, for a total amount of $424,038.</p>
<div class="lb-trans"><p>在所有发现的交易中，有 4 笔是看跌期权，总金额为 411,540 美元，7 笔是看涨期权，总金额为 424,038 美元。</p>
</div><h3>What's The Price Target?</h3>
<div class="lb-trans"><h3>价格目标是什么？</h3>
</div><p>Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $135.0 to $215.0 for Johnson &amp; Johnson during the past quarter.</p>
<div class="lb-trans"><p>分析这些合约的成交量和未平仓合约，似乎大玩家在过去一个季度内关注强生的价格区间为 135.0 美元到 215.0 美元。</p>
</div><h3>Volume &amp; Open Interest Development</h3>
<div class="lb-trans"><h3>成交量与未平仓合约的发展</h3>
</div><p>Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Johnson &amp; Johnson's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Johnson &amp; Johnson's whale trades within a strike price range from $135.0 to $215.0 in the last 30 days.</p>
<div class="lb-trans"><p>查看成交量和未平仓合约是交易期权时的一个强有力的举措。这些数据可以帮助你跟踪强生在特定行权价的期权流动性和兴趣。下面，我们可以观察到过去 30 天内，强生所有鲸鱼交易的看涨和看跌期权的成交量和未平仓合约的演变，行权价范围为 135.0 美元到 215.0 美元。</p>
</div><h3>Johnson &amp; Johnson 30-Day Option Volume &amp; Interest Snapshot</h3>
<div class="lb-trans"><h3>强生 30 天期权成交量与兴趣快照</h3>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2025/1766599293_0.png" alt="Options Call Chart" original-src="https://www.benzinga.com/files/images/story/2025/1766599293_0.png"/></p>
<h3>Significant Options Trades Detected:</h3>
<div class="lb-trans"><h3>发现的重要期权交易：</h3>
</div><table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>JNJ</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$5.7</td>
<td>$5.5</td>
<td>$5.55</td>
<td>$210.00</td>
<td>$222.0K</td>
<td>4.1K</td>
<td align="right">569</td>
</tr>
<tr>
<td>JNJ</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>03/20/26</td>
<td>$29.85</td>
<td>$28.5</td>
<td>$29.44</td>
<td>$180.00</td>
<td>$147.2K</td>
<td>2.3K</td>
<td align="right">50</td>
</tr>
<tr>
<td>JNJ</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$18.5</td>
<td>$17.3</td>
<td>$17.3</td>
<td>$210.00</td>
<td>$103.8K</td>
<td>119</td>
<td align="right">60</td>
</tr>
<tr>
<td>JNJ</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/15/27</td>
<td>$75.65</td>
<td>$72.7</td>
<td>$74.18</td>
<td>$135.00</td>
<td>$74.1K</td>
<td>363</td>
<td align="right">0</td>
</tr>
<tr>
<td>JNJ</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/02/26</td>
<td>$1.13</td>
<td>$1.04</td>
<td>$1.05</td>
<td>$210.00</td>
<td>$60.5K</td>
<td>469</td>
<td align="right">589</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th><strong>代码</strong></th>
<th><strong>看跌/看涨</strong></th>
<th><strong>交易类型</strong></th>
<th><strong>情绪</strong></th>
<th><strong>到期日</strong></th>
<th><strong>卖出价</strong></th>
<th><strong>买入价</strong></th>
<th><strong>价格</strong></th>
<th><strong>行权价</strong></th>
<th><strong>总交易价格</strong></th>
<th><strong>未平仓合约</strong></th>
<th align="right"><strong>成交量</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>JNJ</td>
<td>看跌</td>
<td>扫描</td>
<td>看涨</td>
<td>01/16/26</td>
<td>$5.7</td>
<td>$5.5</td>
<td>$5.55</td>
<td>$210.00</td>
<td>$222.0K</td>
<td>4.1K</td>
<td align="right">569</td>
</tr>
<tr>
<td>JNJ</td>
<td>看涨</td>
<td>交易</td>
<td>看涨</td>
<td>03/20/26</td>
<td>$29.85</td>
<td>$28.5</td>
<td>$29.44</td>
<td>$180.00</td>
<td>$147.2K</td>
<td>2.3K</td>
<td align="right">50</td>
</tr>
<tr>
<td>JNJ</td>
<td>看跌</td>
<td>扫描</td>
<td>看涨</td>
<td>01/15/27</td>
<td>$18.5</td>
<td>$17.3</td>
<td>$17.3</td>
<td>$210.00</td>
<td>$103.8K</td>
<td>119</td>
<td align="right">60</td>
</tr>
<tr>
<td>JNJ</td>
<td>看涨</td>
<td>交易</td>
<td>中性</td>
<td>01/15/27</td>
<td>$75.65</td>
<td>$72.7</td>
<td>$74.18</td>
<td>$135.00</td>
<td>$74.1K</td>
<td>363</td>
<td align="right">0</td>
</tr>
<tr>
<td>JNJ</td>
<td>看涨</td>
<td>扫描</td>
<td>看涨</td>
<td>01/02/26</td>
<td>$1.13</td>
<td>$1.04</td>
<td>$1.05</td>
<td>$210.00</td>
<td>$60.5K</td>
<td>469</td>
<td align="right">589</td>
</tr>
</tbody>
</table>
</div><h3>About Johnson &amp; Johnson</h3>
<div class="lb-trans"><h3>关于强生</h3>
</div><p>Johnson &amp; Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.</p>
<div class="lb-trans"><p>强生是全球最大的、最具多样性的医疗保健公司。它有两个部门：创新药物和医疗技术。自 2023 年剥离消费业务 Kenvue 以来，这两个部门现在代表了公司所有的销售。在 2023-24 年的重组后，药物部门专注于三个主要治疗领域：免疫学、肿瘤学和神经学。从地域上看，超过一半的总收入来自美国。</p>
</div><p>Following our analysis of the options activities associated with Johnson &amp; Johnson, we pivot to a closer look at the company's own performance.</p>
<div class="lb-trans"><p>在分析了与强生相关的期权活动后，我们转向更仔细地观察公司的自身表现。</p>
</div><h3>Current Position of Johnson &amp; Johnson</h3>
<div class="lb-trans"><h3>强生的当前状况</h3>
</div><ul>
<li>Currently trading with a volume of 1,499,052, the JNJ's price is down by -0.07%, now at $205.64.</li>
<li>RSI readings suggest the stock is currently is currently neutral between overbought and oversold.</li>
<li>Anticipated earnings release is in 28 days.</li>
</ul>
<div class="lb-trans"><ul>
<li>当前交易量为 1,499,052，JNJ 的价格下跌了-0.07%，现为 205.64 美元。</li>
<li>RSI 读数表明该股票目前在超买和超卖之间处于中性状态。</li>
<li>预计收益发布将在 28 天内进行。</li>
</ul>
</div><h3>What The Experts Say On Johnson &amp; Johnson</h3>
<div class="lb-trans"><h3>专家对强生的看法</h3>
</div><p>A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $223.8.</p>
<div class="lb-trans"><p>在过去 30 天内，共有 5 位专业分析师对该股票发表了看法，设定的平均价格目标为 223.8 美元。</p>
</div><p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<div class="lb-trans"><p><strong>发现异常期权活动：聪明资金在行动</strong></p>
</div><p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. Click here for access.
* An analyst from RBC Capital persists with their Outperform rating on Johnson &amp; Johnson, maintaining a target price of $230.
* An analyst from B of A Securities has decided to maintain their Neutral rating on Johnson &amp; Johnson, which currently sits at a price target of $220.
* An analyst from Morgan Stanley persists with their Equal-Weight rating on Johnson &amp; Johnson, maintaining a target price of $197.
* An analyst from Goldman Sachs has decided to maintain their Buy rating on Johnson &amp; Johnson, which currently sits at a price target of $240.
* Consistent in their evaluation, an analyst from Citigroup keeps a Buy rating on Johnson &amp; Johnson with a target price of $232.</p>
<div class="lb-trans"><p>Benzinga Edge 的异常期权板块在潜在市场动向发生之前发现可能的市场推动者。查看大资金在你喜欢的股票上采取了什么头寸。点击这里访问。
* RBC Capital 的一位分析师坚持对强生的跑赢大盘评级，维持目标价为 230 美元。
* B of A Securities 的一位分析师决定维持对强生的中性评级，目前的目标价为 220 美元。
* 摩根士丹利的一位分析师坚持对强生的等权评级，维持目标价为 197 美元。
* 高盛的一位分析师决定维持对强生的买入评级，目前的目标价为 240 美元。
* 花旗的一位分析师在评估中保持对强生的买入评级，目标价为 232 美元。</p>
</div><p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Johnson &amp; Johnson with Benzinga Pro for real-time alerts.</p>
<div class="lb-trans"><p>交易期权涉及更大的风险，但也提供了更高的利润潜力。精明的交易者通过持续教育、战略交易调整、利用各种指标以及关注市场动态来降低这些风险。通过 Benzinga Pro 跟踪强生的最新期权交易，获取实时警报。</p>
</div>

强生的选择：深入了解大资金的想法